Effect of Nicotine on Immune System Function

Overview

Journal Adv Pharm Bull

Date 2023 Feb 1

PMID 36721811

Authors

Leila Mahmoudzadeh

Seyyed Meysam Abtahi Froushani

Marjan Ajami

Maryam Mahmoudzadeh

Affiliations

Soon will be listed here.

Abstract

As a parasympathetic alkaloid and the main substance in cigarette smoke, nicotine modulates the immune system, inhibits innate and acquired immunity and is used in treating many autoimmune diseases. It often stimulates the α7 receptor and causes an anti-inflammatory state in the body. This study is designed to evaluate the role of nicotine treatment on immune system. The results showed that nicotine affects many cells in immune system, alters the downstream intracellular mechanisms and changes lymphocytes polarization. This substance alters TLRs and STATs gene expression and thus changes in the innate immune system. All these events inhibit the secretion of pro-inflammatory cytokines and chemokines which increase angiogenesis and metastasis and exacerbates tumors due to increasing survival and cell growth. Nicotine can aggravate tumors in cancer patients, with many positive effects observed in the treating autoimmune disease, Nicotine treatment function in different conditions depends on factors such as concentration, how it is employed, treatment duration and other conditions such as body conditions affecting the immune system, hence, further studies and review of all conditions are required.

Citing Articles

The Impacts of Vaping on the Cardiovascular System: A Systematic Review of Case Reports.

Nagy S, Abdool A, Rocco O, Shirazi N, Israilov D, Atiquzzaman N Cureus. 2025; 17(1):e77780.

PMID: 39981460 PMC: 11841693. DOI: 10.7759/cureus.77780.

Autoimmune Thyroid Disease and Pregnancy: The Interaction Between Genetics, Epigenetics and Environmental Factors.

Bogovic Crncic T, Curko-Cofek B, Baticic L, Girotto N, Tomas M, Krsek A J Clin Med. 2025; 14(1.

PMID: 39797274 PMC: 11721206. DOI: 10.3390/jcm14010190.

Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

White A, Craig A, Richie D, Corley C, Sadek S, Barton H J Neuroimmunol. 2024; 397:578468.

PMID: 39461120 PMC: 11653054. DOI: 10.1016/j.jneuroim.2024.578468.

Effects of Combustible Cigarettes and Heated Tobacco Products on Systemic Inflammatory Response in Patients with Chronic Inflammatory Diseases.

Kastratovic N, Zdravkovic N, Cekerevac I, Sekerus V, Harrell C, Mladenovic V Diseases. 2024; 12(7).

PMID: 39057115 PMC: 11276168. DOI: 10.3390/diseases12070144.

α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.

Li X, Meng X, Fan H, Wang Y, Jia Y, Jiao J Arch Dermatol Res. 2024; 316(6):269.

PMID: 38795191 DOI: 10.1007/s00403-024-03110-0.

References

West K, Castillo S, Dennis P . Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat. 2003; 5(6):234-48. DOI: 10.1016/s1368-7646(02)00120-6. View

Sopori M . Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002; 2(5):372-7. DOI: 10.1038/nri803. View

Johnson J, Pillai S, Pernazza D, Sebti S, Lawrence N, Chellappan S . Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease. Cancer Res. 2011; 72(2):516-26. PMC: 3261351. DOI: 10.1158/0008-5472.CAN-11-2647. View

Ciancio G, Colina M, La Corte R, Lo Monaco A, De Leonardis F, Trotta F . Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series. Rheumatology (Oxford). 2009; 49(3):501-4. DOI: 10.1093/rheumatology/kep401. View

Baughman R, Iannuzzi M . Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs. 2003; 17(6):425-31. DOI: 10.2165/00063030-200317060-00005. View

Taly A, Corringer P, Guedin D, Lestage P, Changeux J . Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov. 2009; 8(9):733-50. DOI: 10.1038/nrd2927. View

Richardson G, Tucker M, Venzon D, Linnoila R, Phelps R, Phares J . Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993; 119(5):383-90. DOI: 10.7326/0003-4819-119-5-199309010-00006. View

Oloris S, Frazer-Abel A, Jubala C, Fosmire S, Helm K, Robinson S . Nicotine-mediated signals modulate cell death and survival of T lymphocytes. Toxicol Appl Pharmacol. 2009; 242(3):299-309. PMC: 2813922. DOI: 10.1016/j.taap.2009.10.020. View

Yu H, Yang Y, Rajaiah R, Moudgil K . Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies. Arthritis Rheum. 2011; 63(4):981-91. PMC: 3079435. DOI: 10.1002/art.30219. View

10.

Tsurutani J, Castillo S, Brognard J, Granville C, Zhang C, Gills J . Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis. 2005; 26(7):1182-95. DOI: 10.1093/carcin/bgi072. View

11.

Ingram J, Rhodes J, Evans B, Thomas G . Nicotine enemas for active Crohn's colitis: an open pilot study. Gastroenterol Res Pract. 2008; 2008:237185. PMC: 2533102. DOI: 10.1155/2008/237185. View

12.

Ahluwalia B, Moraes L, Magnusson M, Ohman L . Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018; 53(4):379-389. DOI: 10.1080/00365521.2018.1447597. View

13.

Hao J, Simard A, Turner G, Wu J, Whiteaker P, Lukas R . Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors. Exp Neurol. 2010; 227(1):110-9. PMC: 3019302. DOI: 10.1016/j.expneurol.2010.09.020. View

14.

Chatterjee P, Al-Abed Y, Sherry B, Metz C . Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Cell Physiol. 2009; 297(5):C1294-306. PMC: 2777398. DOI: 10.1152/ajpcell.00160.2009. View

15.

Pourtayeb S, Froushani S . Nicotine can modulate the effects of the mesenchymal stem cells on neutrophils. Adv Med Sci. 2017; 62(1):165-170. DOI: 10.1016/j.advms.2016.07.006. View

16.

Rabinovitch A . Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?. Diabetes. 1994; 43(5):613-21. DOI: 10.2337/diab.43.5.613. View

17.

Valdez-Miramontes C, Trejo Martinez L, Torres-Juarez F, Rodriguez Carlos A, Marin-Luevano S, de Haro-Acosta J . Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis. Clin Exp Immunol. 2019; 199(2):230-243. PMC: 6954679. DOI: 10.1111/cei.13388. View

18.

Schaal C, Chellappan S . Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014; 12(1):14-23. PMC: 3915512. DOI: 10.1158/1541-7786.MCR-13-0541. View

19.

Arneric S, Holladay M, Williams M . Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. Biochem Pharmacol. 2007; 74(8):1092-101. DOI: 10.1016/j.bcp.2007.06.033. View

20.

Sun Z, Smyth K, Garcia K, Mattson E, Li L, Xiao Z . Nicotine inhibits memory CTL programming. PLoS One. 2013; 8(7):e68183. PMC: 3699522. DOI: 10.1371/journal.pone.0068183. View